Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5Gastrointestinal 5Other hematologic neoplasm 4Lymphoid 3Dermatologic 3Myeloid 2Genitourinary 2Plasma cell 1Other 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 1Non Small Cell Lung Cancer Metastatic 1Melanoma 1Lung Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 551Pemetrexed 404Cisplatin 401Paclitaxel 273Docetaxel 255Gemcitabine 218pembrolizumab 191Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 181Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 107atezolizumab 92Gefitinib 74Radiosurgery 72anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 50Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Fecal Microbiota Transplantation × Thoracic × Clear all
NCT07432984 2026-02-25

FMT-LUNG

Samsung Medical Center

Phase 2 Not yet recruiting
15 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05286294 2025-07-03

MITRIC

Oslo University Hospital

Phase 2 Active not recruiting
20 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT06403111 2024-12-20

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

Changzhou No.2 People's Hospital

Phase 2 Recruiting
62 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04951583 2024-08-07

FMT-LUMINATE

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Active not recruiting
45 enrolled
DermatologicThoracic

Non Small Cell Lung Cancer Metastatic

NCT05502913 2023-10-02

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

Soroka University Medical Center

Phase 2 Recruiting
80 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡